These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16840174)

  • 1. Rosiglitazone antagonizes vascular endothelial growth factor signaling and nuclear factor of activated T cells activation in cardiac valve endothelium.
    Sander TL; Noll L; Klinkner DB; Weihrauch D; He BJ; Kaul S; Zangwill SD; Tweddell JS; Pritchard KA; Oldham KT
    Endothelium; 2006; 13(3):181-90. PubMed ID: 16840174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-derived microparticles inhibit human cardiac valve endothelial cell function.
    Klinkner DB; Densmore JC; Kaul S; Noll L; Lim HJ; Weihrauch D; Pritchard KA; Oldham KT; Sander TL
    Shock; 2006 Jun; 25(6):575-80. PubMed ID: 16721264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
    Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor (VEGF) and ovarian carcinoma cell supernatant activate signal transducers and activators of transcription (STATs) via VEGF receptor-2 (KDR) in human hemopoietic progenitor cells.
    Ye F; Chen HZ; Xie X; Ye DF; Lu WG; Ding ZM
    Gynecol Oncol; 2004 Jul; 94(1):125-33. PubMed ID: 15262130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis.
    Aljada A; O'Connor L; Fu YY; Mousa SA
    Angiogenesis; 2008; 11(4):361-7. PubMed ID: 18810647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
    Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
    Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells.
    Lombardi A; Cantini G; Piscitelli E; Gelmini S; Francalanci M; Mello T; Ceni E; Varano G; Forti G; Rotondi M; Galli A; Serio M; Luconi M
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):718-24. PubMed ID: 18239149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism.
    Biscetti F; Gaetani E; Flex A; Aprahamian T; Hopkins T; Straface G; Pecorini G; Stigliano E; Smith RC; Angelini F; Castellot JJ; Pola R
    Diabetes; 2008 May; 57(5):1394-404. PubMed ID: 18268046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a PPAR-gamma agonist, on growth factor and insulin stimulated endothelial cells.
    Desouza CV; Gerety M; Hamel FG
    Vascul Pharmacol; 2009; 51(2-3):162-8. PubMed ID: 19520186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells.
    Cheng Y; Ping J; Xu LM
    Chin Med J (Engl); 2007 May; 120(9):794-801. PubMed ID: 17531121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.
    Dardik R; Inbal A
    Exp Cell Res; 2006 Oct; 312(16):2973-82. PubMed ID: 16914140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
    Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance.
    Tencer L; Burgermeister E; Ebert MP; Liscovitch M
    Anticancer Res; 2008; 28(2A):895-906. PubMed ID: 18507034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy.
    Suwaki N; Masuyama H; Masumoto A; Takamoto N; Hiramatsu Y
    Placenta; 2007 Apr; 28(4):315-23. PubMed ID: 16753211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
    Duan SZ; Usher MG; Mortensen RM
    Circ Res; 2008 Feb; 102(3):283-94. PubMed ID: 18276926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells.
    Clarkin CE; Emery RJ; Pitsillides AA; Wheeler-Jones CP
    J Cell Physiol; 2008 Feb; 214(2):537-44. PubMed ID: 17685428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain.
    Yu P; Passam FH; Yu DM; Denyer G; Krilis SA
    J Thromb Haemost; 2008 Jul; 6(7):1215-23. PubMed ID: 18452581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C-delta mediates von Willebrand factor secretion from endothelial cells in response to vascular endothelial growth factor (VEGF) but not histamine.
    Lorenzi O; Frieden M; Villemin P; Fournier M; Foti M; Vischer UM
    J Thromb Haemost; 2008 Nov; 6(11):1962-9. PubMed ID: 18752579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells.
    Johnson EN; Lee YM; Sander TL; Rabkin E; Schoen FJ; Kaushal S; Bischoff J
    J Biol Chem; 2003 Jan; 278(3):1686-92. PubMed ID: 12427739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.